<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">27956634</PMID>
<DateCompleted>
<Year>2018</Year>
<Month>04</Month>
<Day>13</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1091-6490</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>113</Volume>
<Issue>52</Issue>
<PubDate>
<Year>2016</Year>
<Month>12</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
<ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
</Journal>
<ArticleTitle>Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in mice.</ArticleTitle>
<Pagination>
<MedlinePgn>E8425-E8432</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1618548114</ELocationID>
<Abstract>
<AbstractText>Constitutive proteasomes (c-20S) are ubiquitously expressed cellular proteases that degrade polyubiquitinated proteins and regulate cell functions. An isoform of proteasome, the immunoproteasome (i-20S), is highly expressed in human T cells, dendritic cells (DCs), and B cells, suggesting that it could be a potential target for inflammatory diseases, including those involving autoimmunity and alloimmunity. Here, we describe DPLG3, a rationally designed, noncovalent inhibitor of the immunoproteasome chymotryptic subunit β5i that has thousands-fold selectivity over constitutive β5c. DPLG3 suppressed cytokine release from blood mononuclear cells and the activation of DCs and T cells, diminished accumulation of effector T cells, promoted expression of exhaustion and coinhibitory markers on T cells, and synergized with CTLA4-Ig to promote long-term acceptance of cardiac allografts across a major histocompatibility barrier. These findings demonstrate the potential value of using brief posttransplant immunoproteasome inhibition to entrain a long-term response favorable to allograft survival as part of an immunomodulatory regimen that is neither broadly immunosuppressive nor toxic.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sula Karreci</LastName>
<ForeName>Esilida</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Fan</LastName>
<ForeName>Hao</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY 10065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Uehara</LastName>
<ForeName>Mayuko</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mihali</LastName>
<ForeName>Albana B</ForeName>
<Initials>AB</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Singh</LastName>
<ForeName>Pradeep K</ForeName>
<Initials>PK</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry, Milstein Chemistry Core Facility, Weill Cornell Medicine, New York, NY 10065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kurdi</LastName>
<ForeName>Ahmed T</ForeName>
<Initials>AT</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Solhjou</LastName>
<ForeName>Zhabiz</ForeName>
<Initials>Z</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Riella</LastName>
<ForeName>Leonardo V</ForeName>
<Initials>LV</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghobrial</LastName>
<ForeName>Irene</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Laragione</LastName>
<ForeName>Teresina</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY 10021.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Routray</LastName>
<ForeName>Sujit</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Assaker</LastName>
<ForeName>Jean Pierre</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Rong</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>NMR Analytical Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sukenick</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>NMR Analytical Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shi</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barrat</LastName>
<ForeName>Franck J</ForeName>
<Initials>FJ</Initials>
<AffiliationInfo>
<Affiliation>Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY 10021.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nathan</LastName>
<ForeName>Carl F</ForeName>
<Initials>CF</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY 10065; cnathan@med.cornell.edu gal2005@med.cornell.edu jazzi@rics.bwh.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lin</LastName>
<ForeName>Gang</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Weill Cornell Medicine, New York, NY 10065; cnathan@med.cornell.edu gal2005@med.cornell.edu jazzi@rics.bwh.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Azzi</LastName>
<ForeName>Jamil</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; cnathan@med.cornell.edu gal2005@med.cornell.edu jazzi@rics.bwh.harvard.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R21 AI123794</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>12</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
<NlmUniqueID>7505876</NlmUniqueID>
<ISSNLinking>0027-8424</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016207">Cytokines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061988">Proteasome Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.25.1</RegistryNumber>
<NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D049109">Cell Proliferation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016207">Cytokines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003713">Dendritic Cells</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D006085">Graft Survival</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016027">Heart Transplantation</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D056945">Hep G2 Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007156">Immunologic Memory</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007166">Immunosuppressive Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007963">Leukocytes, Mononuclear</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D051379">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008807">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008810">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D046988">Proteasome Endopeptidase Complex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D061988">Proteasome Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000494">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013601">T-Lymphocytes</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">T-cell exhaustion</Keyword>
<Keyword MajorTopicYN="Y">allograft</Keyword>
<Keyword MajorTopicYN="Y">effector T cells</Keyword>
<Keyword MajorTopicYN="Y">immunoproteasome</Keyword>
<Keyword MajorTopicYN="Y">memory T cells</Keyword>
</KeywordList>
<CoiStatement>The authors declare no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2018</Year>
<Month>4</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>12</Month>
<Day>14</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">27956634</ArticleId>
<ArticleId IdType="pii">1618548114</ArticleId>
<ArticleId IdType="doi">10.1073/pnas.1618548114</ArticleId>
<ArticleId IdType="pmc">PMC5206568</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Am Chem Soc. 2013 Jul 10;135(27):9968-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23782398</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Soc Trans. 2007 Feb;35(Pt 1):12-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17212580</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2011 Oct;121(10):3889-901</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21911939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2008 Mar 13;3(3):137-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18329613</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2014 May 29;509(7502):582-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24870543</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Immunol. 2011 Jun;12(6):492-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21739672</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin HIV AIDS. 2014 Sep;9(5):439-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25010894</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1994 Sep 9;78(5):761-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8087844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2009 Jul;15(7):781-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19525961</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bioorg Med Chem Lett. 2014 Aug 1;24(15):3614-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24913713</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12145-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25092331</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2005 Sep 1;65(17):7896-901</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16140960</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Chem Soc. 2015 Jun 24;137(24):7835-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26020686</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 1998 Jan 5;187(1):97-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9419215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16004-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23012453</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2010 Jul 1;185(1):634-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20525886</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 1998 Feb 6;92(3):367-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9476896</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplant Proc. 1973 Mar;5(1):733-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4572133</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2011 Jan 13;117(2):500-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20956804</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1999 Dec 3;274(49):35196-202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10575004</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Med. 2006 Aug 7;203(8):1999-2008</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16864658</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Rheum. 2012 Feb;64(2):493-503</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21905015</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>EMBO Mol Med. 2014 Feb;6(2):226-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24399752</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2009 Oct 1;461(7264):621-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19759536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ChemMedChem. 2016 Oct 6;11(19):2127-2131</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27561172</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2008 Jul;14(7):748-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18542049</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Med Chem Lett. 2014 Feb 03;5(4):405-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24900849</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem J. 2010 Sep 15;430(3):461-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20632995</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2014 May 29;509(7502):575-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24870542</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2015 Jul 30;523(7562):612-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26123020</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2012 Feb 17;148(4):727-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22341445</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Chem. 2000 May;46(5):673-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10794750</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>